UUP NEWS! 21.27 DB US Dollar Index Bullish Powershares (UUP)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
DB US Dollar Index Bullish Powershares (UUP) 21.27 $UUP

3 Ways to Profit if You're Bearish on the Greenback
at The Street - Mon Mar 24, 10:30AM CDT
Investors can still gain from the negative outlook on U.S. Government debt.

Why the Yen Will Sell Off Now
at The Street - Wed Mar 19, 10:38AM CDT
The Japanese currency is likely to experience selling pressure from weaker Japanese exports and the likelihood of tighter U.S. monetary policy.

U.S. Dollar ETFs Reaching a Turning Point
Richard Cox, The Motley Fool - Motley Fool - Tue Mar 04, 1:32PM CST
The year so far has been marked by generalized weakness in the U.S. dollar, and the PowerShares DB US Dollar Index Bullish ETF is now approaching its 52-week low of $21.32. But whether or not these trends actually match the underlying fundamentals...

Global Macro: Market Fears War, Global Assets Tumble
at The Street - Tue Mar 04, 5:00AM CST
Russia gives Ukraine an ultimatum and investors flee global equities for safety.

Jobs, Inflation Numbers to Weigh on Euro
Richard Cox, The Motley Fool - Motley Fool - Wed Feb 05, 3:25PM CST
The euro is now trading at its weakest level since November and is pressured mostly by unfavorable macro data that suggests the region's systemic debt problems have not completely run their course. At the end of last year, currency pairs like the...

Play a Rising Dollar with These ETFs - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Tue Jan 14, 9:00AM CST
Are you looking for the dollar to rise? Try either of these dollar bull ETFs.

Where Will Global Currency ETFs Go in 2014? - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Fri Jan 03, 5:03AM CST
The US dollar starts the year on a bullish note; will it continue its uptrend?

'Fast Money' Recap: A New Year's Hangover
at The Street - Fri Jan 03, 4:00AM CST
The trading panel looked at the S&P500 and where it's headed next.

Bank of Japan No Friend to the Yen
Richard Cox, The Motley Fool - Motley Fool - Thu Jan 02, 2:17PM CST
In May of 2013 I issued a trading recommendation to sell assets tied to the Japanese yen. Since then, ETFs like the  CurrencyShares Japanese Yen Trust , which tracks the value of the yen against its most commonly traded counterparts, has fallen...

WisdomTree Launches Dollar Bullish Fund - ETF News And Commentary
Zacks Equity Research - ZACKS - Mon Dec 23, 11:08AM CST
The product could be a solid choice for investors who expect the US dollar to appreciate in the coming months.

Contract awarded for Christchurch state housing minor repairs programme
M2 - Thu Dec 19, 7:41AM CST
Housing Minister Dr Nick Smith today announced that Project Management Company MWH (New Zealand) had been awarded the contract to manage the minor repairs programme for 3600 earthquake damaged Christchurch state houses with less than $40,000 worth of damage.

6 Top Goldman Sachs Trades for 2014
at The Street - Thu Dec 12, 7:48AM CST
Goldman Sachs makes its top picks for 2014 in equities, commodities, currency and credit.

Swiss Franc Still a Sell After Recent Rallies
Richard Cox, The Motley Fool - Motley Fool - Wed Dec 04, 4:35PM CST
Most of the attention in the currency markets continues to center on the U.S. dollar and any potential volatility that could be seen if the Federal Reserve starts to signal an end date for its quantitative-easing programs. Of course, a scenario like...

Will Better Technology Deflate Bitcoin Fever?
Ron DeLegge - ETFG - Wed Nov 27, 10:40PM CST
Bitcoin is a technological solution and competing digital currencies that are faster, more secure, and easier to use are just ahead.

Short the Euro with These Inverse Currency ETFs - ETF News And Commentary
Zacks Equity Research - ZACKS - Wed Nov 13, 9:01AM CST
Are you looking to bet against the euro? Consider any of these inverse currency ETFs.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 113

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 352

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 377

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 225

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 416

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 115

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 349

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 266

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Scent Dispensing Solution for Hunting Enthusiasts

Updated Category News Views 168

Introducing a Game-Changing Scent Dispensing System In the world of hunting, attracting game animals can often be a challenge. A new invention, designed specifically for this purpose, promises to make the process much simpler and more efficient. The inventor of this innovative scent dispensing system, THE DRAG LINE PRO, envisioned a better way to utilize a scent drag...

Continue Reading
Corby Spirit and Wine Limited Reports Impressive Fiscal Results

Updated Category News Views 295

Corby Spirit and Wine Limited Announces Strong Fiscal Performance Corby Spirit and Wine Limited, renowned for its position as a leading Canadian manufacturer, marketer, and importer of spirits, has recently unveiled impressive results for its fourth quarter and full-year fiscal 2025. The company demonstrated significant growth in revenue, achieving total revenues of...

Continue Reading
Sezzle Faces Setback as Short-Seller Targets Its Practices

Updated Category News Views 113

Sezzle's Stock Takes a Dramatic Hit Recently, the buy now, pay later (BNPL) provider Sezzle experienced a significant decrease in its stock value. Reports indicate that shares fell over 28.6% in early trading after Hindenburg Research disclosed a short position against the company due to concerns surrounding risky lending practices. Understanding the Short-Selling...

Continue Reading
Exploring the Growth of $1000 in Marsh & McLennan Cos Today

Updated Category News Views 116

Understanding Long-Term Investment in Marsh & McLennan Marsh & McLennan Cos (NYSE: MMC) has established itself as a financial powerhouse, outperforming the market consistently over the past two decades. Investors have experienced an impressive annualized return of 13.31%, showcasing the benefits of long-term investment strategies. The Value of Persistence in Investing...

Continue Reading
Discover Toll Brothers' Latest Luxury Homes at Overbrook Estates

Updated Category News Views 671

Introducing Overbrook Estates by Toll Brothers Toll Brothers, Inc. (NYSE:TOL), a renowned name in luxury homebuilding, excitedly unveils its newest community: Overbrook Estates. This anticipated project is set to grace the Huntersville area, offering homebuyers elegant living in a master-planned environment. Positioned conveniently off Highway 77, this prime location sets...

Continue Reading